Cargando…

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer

BACKGROUND: Lysosome-associated protein transmembrane 4b-35 (LAPTM4B-35) is a member of the mammalian 4-tetratransmembrane spanning protein superfamily, which is overexpressed in several solid malignancies. However, the expression of LAPTM4B-35 and its role in the progression of prostate cancer (PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hongtuan, Wei, Qiang, Liu, Ranlu, Qi, Shiyong, Liang, Peihe, Qi, Can, Wang, Andi, Sheng, Bin, Li, Liang, Xu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961215/ https://www.ncbi.nlm.nih.gov/pubmed/24651764 http://dx.doi.org/10.1371/journal.pone.0091069

Ejemplares similares

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

Expression of RABEX-5 and its clinical significance in prostate cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer
por: Zhang, Hongtuan, et al.
Publicado: (2013)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy
por: Zhang, Hongtuan, et al.
Publicado: (2023)

LAPTM4B-35 protein is a weak tumor-associated antigen candidate
por: SHI, GUILAN, et al.
Publicado: (2014)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015)

Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress
por: Jiang, Xingkang, et al.
Publicado: (2016)

Clinical significance of NUCB2 mRNA expression in prostate cancer
por: Zhang, Hongtuan, et al.
Publicado: (2013)

Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis
por: Zhang, Hongtuan, et al.
Publicado: (2012)

Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression
por: Zhang, Hongtuan, et al.
Publicado: (2018)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

CtBP2 overexpression is associated with tumorigenesis and poor clinical outcome of prostate cancer
por: Zhang, Changwen, et al.
Publicado: (2015)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma
por: Fan, Jianlin, et al.
Publicado: (2020)

SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B
por: Xie, Cheng-Rong, et al.
Publicado: (2017)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
por: Zhang, Yixiang, et al.
Publicado: (2017)

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
por: Ouyang, Jiayue, et al.
Publicado: (2022)

LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors
por: Li, Xiunan, et al.
Publicado: (2021)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics
por: Liu, Minxia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2nscqij543d843sogg7uin2si